Xilai Ding
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Hepatology top 5%
- Hepatitis C virus research
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 8
- Immune Response and Inflammation 4
- T-cell and B-cell Immunology 3
-
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Lei Jin (1 shared paper)Ming Shi (1 shared paper)Zhengsheng Zou (1 shared paper)Zirong Tang (1 shared paper)Yang‐Xin Fu (1 shared paper)Bin Zhang (1 shared paper)Chun‐Bao Zhou (1 shared paper)Junliang Fu (1 shared paper)
- Journals
- The Journal of Immunology (5 papers)PLoS ONE (2 papers)Nature Communications (1 paper)Chemical Communications (1 paper)Cancer Biomarkers (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xilai Ding
19 papers receiving 926 citations
Peers
Comparison fields: 5 of 91
- Immunology 468
- Hepatology 146
- Epidemiology 268
- Oncology 91
- Hematology 36
Countries citing papers authored by Xilai Ding
This map shows the geographic impact of Xilai Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilai Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilai Ding more than expected).
Fields of papers citing papers by Xilai Ding
This network shows the impact of papers produced by Xilai Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilai Ding. The network helps show where Xilai Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xilai Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 375 | |
| 2 | 2014 | 124 | |
| 3 | 2016 | 96 | |
| 4 | 2018 | 60 | |
| 5 | 2014 | 51 | |
| 6 | 2013 | 45 | |
| 7 | 2011 | 40 | |
| 8 | 2022 | 30 | |
| 9 | 2012 | 24 | |
| 10 | 2012 | 21 | |
| 11 | 2010 | 21 | |
| 12 | 2022 | 18 | |
| 13 | 2011 | 13 | |
| 14 | 2024 | 7 | |
| 15 | [Identification of potential neoplastic risk in gonadal development abnormality with Y chromosome of 79 cases]. | 2008 | 2 |
| 16 | [Role of positron emission tomography in diagnosis of recurrent ovarian cancer]. | 2003 | 2 |
| 17 | [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors]. | 2013 | 2 |
| 18 | 2013 | 1 | |
| 19 | 2013 | 1 | |
| 20 | 2020 | 0 |
About Xilai Ding
Xilai Ding is a scholar working on Immunology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 20 papers that have together received 933 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers), Immune Response and Inflammation (4 papers), T-cell and B-cell Immunology (3 papers), Testicular diseases and treatments (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (468 citations), Hepatology (146 citations), Epidemiology (268 citations), Oncology (91 citations) and Hematology (36 citations). Xilai Ding has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lei Jin, Ming Shi, Zhengsheng Zou, Zirong Tang, Yang‐Xin Fu, Bin Zhang, Chun‐Bao Zhou, Junliang Fu, Dongping Xu and Fu‐Sheng Wang. Their work appears in journals such as The Journal of Immunology, PLoS ONE, Nature Communications, Chemical Communications and Cancer Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.